121 related articles for article (PubMed ID: 6156614)
1. Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon.
Cheeseman SH; Henle W; Rubin RH; Tolkoff-Rubin NE; Cosimi B; Cantell K; Winkle S; Herrin JT; Black PH; Russell PS; Hirsch MS
Ann Intern Med; 1980 Jul; 93(1):39-42. PubMed ID: 6156614
[TBL] [Abstract][Full Text] [Related]
2. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.
Cheeseman SH; Rubin RH; Stewart JA; Tolkoff-Rubin NE; Cosimi AB; Cantell K; Gilbert J; Winkle S; Herrin JT; Black PH; Russell PS; Hirsch MS
N Engl J Med; 1979 Jun; 300(24):1345-9. PubMed ID: 220536
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft.
Pass RF; Whitley RJ; Diethelm AG; Whelchel JD; Reynolds DW; Alford CA
J Infect Dis; 1980 Jul; 142(1):9-17. PubMed ID: 6249875
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression.
Gaston JS; Rickinson AB; Epstein MA
Lancet; 1982 Apr; 1(8278):923-5. PubMed ID: 6122768
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G
J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105
[TBL] [Abstract][Full Text] [Related]
7. Impaired lymphocyte transformation response to cytomegalovirus and phytohemagglutinin in recipients of renal transplants: association with antithymocyte globulin.
Pass RF; Reynolds DW; Whelchel JD; Diethelm AG; Alford CA
J Infect Dis; 1981 Feb; 143(2):259-65. PubMed ID: 6260873
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.
Fiala M; Payne JE; Berne TV; Moore TC; Henle W; Montgomerie JZ; Chatterjee SN; Guze LB
J Infect Dis; 1975 Oct; 132(4):421-33. PubMed ID: 171315
[TBL] [Abstract][Full Text] [Related]
9. Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update.
Hertig A; Zuckermann A
Transpl Immunol; 2015 Jun; 32(3):179-87. PubMed ID: 25936966
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS
Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183
[TBL] [Abstract][Full Text] [Related]
11. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
[TBL] [Abstract][Full Text] [Related]
12. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
[No Abstract] [Full Text] [Related]
13. Impact of immunosuppression on the development of Epstein-Barr virus (EBV) viremia after pediatric liver transplantation.
Lu BR; Park KT; Hurwitz M; Cox KL; Berquist WE
Transplant Proc; 2013; 45(1):301-4. PubMed ID: 23267800
[TBL] [Abstract][Full Text] [Related]
14. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
15. Use of antithymocyte globulin (dose by rosette protocol) in pediatric renal allograft recipients.
Uittenbogaart CH; Robinson BJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Fine RN
Transplantation; 1979 Oct; 28(4):291-3. PubMed ID: 388761
[TBL] [Abstract][Full Text] [Related]
16. Mononuclear subsets during cytomegalovirus disease in renal transplant recipients treated with cyclosporine and rabbit antithymocyte globulin.
Metselaar HJ; Rothbarth PH; Wenting GJ; Vaessen LB; Masurel N; Jeekel J; Weimar W
J Med Virol; 1986 May; 19(1):95-100. PubMed ID: 3009707
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
Cosimi AB; Wortis HH; Delmonico FL; Russell PS
Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
[TBL] [Abstract][Full Text] [Related]
18. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
[No Abstract] [Full Text] [Related]
19. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation.
Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Winters GL; Pifarre R; Radvany R; Zucker MJ; Scanlon PJ; Robinson JA
J Heart Transplant; 1990; 9(3 Pt 2):306-15. PubMed ID: 2113094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
